Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review

Hormone receptor-positive HER2-positive (HR+/HER2+) metastatic breast cancer (MBC) is a unique subtype of breast cancer. Most current guidelines recommend that combination regimens based on anti-HER2 therapy should be used as first-line treatment for HER2+ MBC, irrespective of HR status. Endocrine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Ran, Ma, Yingying, Wang, Hui, Yang, Jin, Yang, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822772/
https://www.ncbi.nlm.nih.gov/pubmed/36620573
http://dx.doi.org/10.3389/fonc.2022.975463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822772/
https://www.ncbi.nlm.nih.gov/pubmed/36620573
http://dx.doi.org/10.3389/fonc.2022.975463

Ejemplares similares